The C-peptide fragment EVARQ reduces glomerular hyperfiltration in streptozotocin-induced diabetic rats

Diabetes/Metabolism Research and Reviews

Volumn 23, Issue 5, 2007, Pages 400-405

  Nordquist, Lina ^a   Moe, Erika ^a   Sjöquist, Mats ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

C peptide; Diabetes; EVARQ; Glomerular filtration rate; Kidney function; Rats

Indexed keywords

ANTIDIABETIC AGENT; C PEPTIDE; GLUCOSE; GLUTAMYLVALYLALANYLARGINYLGLUTAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETES MELLITUS; GLOMERULAR DYSFUNCTION; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; IN VIVO STUDY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN STRUCTURE; RAT; RENAL PROTECTION; SPRAGUE DAWLEY RAT; STREPTOZOCIN DIABETES; TREATMENT DURATION;

ANIMALS; C-PEPTIDE; DIABETES MELLITUS, EXPERIMENTAL; GLOMERULAR FILTRATION RATE; KIDNEY GLOMERULUS; MALE; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34447624323     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.704     Document Type: Article

References (31)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
2. Berg UB, Torbjornsdotter TB, Jaremko G, et al. Kidney morphological changes in relation to long-term renal function and metabolic control in adolescents with IDDM. Diabetologia 1998; 41: 1047-1056.
3. Yip JW, Jones SL, Wiseman MJ, et al. Glomerular hyperfiltration in the prediction of nephropathy in IDDM: a 10-year follow-up study. Diabetes 1996; 45: 1729-1733.
4. Marre M, Hallab M, Roy J, et al. Glomerular hyperfiltration in type I, type II, and secondary diabetes. J Diabetes Complicat 1992; 6: 19-24.
5. Huang DY, Richter K, Breidenbach A, et al. Human C-peptide acutely lowers giomerular hyperfiltration and proteinuria in diabetic rats: a dose-response study. Naunyn Schmiedebergs Arch Pharmacol 2002; 365: 67-73.
6. Johansson BL, Borg K, Fernqvist-Forbes E, et al. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type I diabetes mellitus. Diabet Med 2000; 17: 181-189.
7. Forst T, Kunt T, Pfutzner A, et al. New aspects on biological activity of C-peptide in IDDM patients. Exp Clin Endocrinol Diabetes 1998; 106: 270-276.
8. Sjoquist M, Huang W, Johansson BL. Effects of C-peptide on renal function at the early stage of experimental diabetes. Kidney Int 1998; 54: 758-764.
9. Samnegard B, Jacobson SH, Jaremko G, et al. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Kidney Int 2001; 60: 1258-1265.
10. Wahren J, Ekberg K, Johansson J, et al. Role of C-peptide in human physiology. Am J Physiol Endocrinol Metab 2000; 278: E759-E768.
11. Wahren J. C-peptide: new findings and therapeutic implications in diabetes. Clin Physiol Funct Imaging 2004; 24: 180-189.
12. Samnegard B, Jacobson SH, Johansson BL, et al. C-peptide and captopril are equally effective in lowering giomerular hyperfiltration in diabetic rats. Nephrol Dial Transplant 2004; 19: 1385-1391.
13. Vague P, Dufayet D, Lamotte MP, et al. Genetic factors, Na K ATPase activity and neuropathy in diabetics. Bull Acad Natl Med 1997; 181: 1811-1821.
14. Smith JM, Paulson DJ, Solar SM. Na +/K(-+)-ATPase activity in vascular smooth muscle from streptozotocin diabetic rat. Cardiovasc Res 1997; 34: 137-144.
15. Korner A, Eklof AC, Celsi G, et al. Increased renal metabolism in diabetes. Mechanism and functional implications. Diabetes 1994; 43: 629-633.
16. Golfman L, Dixon IM, Takeda N, et al. Cardiac sarcolemmal Na(+)-Ca24- exchange and Na(-F)-K+ ATPase activities and gene expression in alloxan-induced diabetes in rats. Mol Cell Biochem 1998; 188: 91-101.
17. Chen CC. Differentiation of renal Na(+)-K(+)-ATPase in control and streptozotocin-induced diabetic mice by G-protein acting toxins and phorbol esters. Eur J Pharmacol 1992; 225: 275-279.
18. Tehrani ST, Yamamoto JJ, Garner MH. Na(-+)-K(+)-ATPase and changes in ATP hydrolysis, monovalent cation affinity, and K+ occlusion in diabetic and galactosemic rats. Diabetes 1990; 39: 1472-1478.
19. Garner MH. Changes in Na, K-adenosine triphosphatase (ATPase) concentration and Na,K-ATPase-dependent adenosine triphosphate turnover in human erythrocytes in diabetes. Metabolism 1996; 45: 927-934.
20. Pramanik A, Ekberg K, Zhong Z, et al. C-peptide binding to human cell membranes: importance of Glu27. Biochem Biophys Res Commun 2001; 284: 94-98.
21. Ohtomo Y, Bergman T, Johansson BL, et al. Differential effects of proinsulin G-peptide fragments on Na+, K+-ATPase activity of renal tubule segments. Diabetologia 1998; 41: 287-291.
22. Rigler R, Pramanik A, Jonasson P, et al. Specific binding of proinsulin G-peptide to human cell membranes. Proc Natl Acad Sci USA 1999; 96: 13318-13323.
23. Junod A, Lambert AE, Stauffacher W, et al. Diabetogenic action of streptozotocin: relationship of dose to metabolic response. J Clin Invest 1969; 48: 2129-2139.
24. Melles E, Bergman T, Alvelius G, et al. Proinsulin G-peptide and its C-terminal pentapeptide: degradation in human serum and Schiff base formation with subsequent CO2 incorporation. Cell Mol Life Sci 2003; 60: 1019-1025.
25. Kuzuya T, Matsuda A. Disappearance rate of endogenous human G-peptide from blood. Diabetologia 1976; 12: 519-521.
26. Krause U, Cordes U, Beyer J. C-peptide: secretion and metabolism in different functional states and with abnormal B-cell function. Dtsch Med Wochenschr 1977; 102: 785-790.
27. Rizk N, Dunbar JC. Insulin-mediated increase in sympathetic nerve activity is attenuated by C-peptide in diabetic rats. Exp Biol Med (Maywood) 2004; 229: 80-84.
28. Li L, Oshida Y, Kusunoki M, et al. Rat C peptide I and II stimulate glucose utilization in STZ-induced diabetic rats. Diabetologia 1999; 42: 958-964.
29. Sato Y, Oshida Y, Han YQ, et al. C-peptide fragments stimulate glucose utilization in diabetic rats. Cell Mol Life Sci 2004; 61: 727-732.
30. Park SK, Meyer TW. The effect of hyperglycemia on glomerular function in obese Zucker rats. J Lab Clin Med 1995; 125: 501-507.
31. Tucker BJ, Mendonca MM, Blantz RC. Contrasting effects of acute insulin infusion on renal function in awake nondiabetic and diabetic rats. J Am Soc Nephrol 1993; 3: 1686-1693.